Gemina Laboratories Ltd.

    Gemina Laboratories Ltd.

    CCSE:GLAB
    - -
    CAD
    - -
    - -
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    -0.1
    -0.1
    -0.07
    -0.06
    -0.05
    Free Cash Flow per Basic Share
    - -
    -0.08
    -0.08
    -0.05
    -0.02
    -0.01
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    - -
    -0.06
    -0.08
    -0.12
    -0.12
    Tangible Book Value per Share
    - -
    0.02
    - -
    -0.02
    -0.06
    -0.06
    Basic Weighted Avg Shares
    - -
    48
    60
    72
    74
    75
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    -35,059.93
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    -5
    -6
    -5
    -4
    -4
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    -36,846.4
    Working Capital
    - -
    1
    -1
    -3
    -6
    -5
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    - -
    1
    - -
    -2
    -4
    -4
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -4,444.43
    - -
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Oct'25
    Jan'25
    Apr'26
    ST Debt
    1
    1
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    75
    75
    77
    Market Capitalization
    28
    40
    76

    Working Capital

    CAD

    •

    in mil. unless spec.
    Oct'25
    Jan'25
    Apr'26
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    5
    6
    6
    Payables & Accruals
    4
    5
    5
    ST Debt
    1
    1
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    179.78%
    Free Cash Flow
    - -
    - -
    -60.4%
    Net Income, GAAP
    - -
    - -
    -21.91%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -0.02
    -0.02
    -0.02
    - -
    -0.07
    2025
    -0.01
    -0.01
    -0.01
    - -
    -0.06
    2026
    -0.01
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business